Gregory A. Morris, Ph.D., joins Honigman’s growing IP practice
Gregory A. Morris joins Honigman Miller Schwartz and Cohn LLP as a partner in its Intellectual Property Department and leader of its Life Sciences Litigation Practice Group. He will be located in the firm’s Chicago office. The firm’s IP practice, which has added 12 attorneys this year alone, serves clients nationally and internationally.
Morris has more than 10 years of experience as an IP litigator. He focuses his practice on patent infringement actions involving pharmaceutical, biotechnology and medical device technologies. He also has significant experience representing clients in inter partes review (IPR) trial proceedings involving patent validity challenges before the United States Patent and Trademark Office. Last fall, Morris successfully argued one of the first IPR cases involving a pharmaceutical patent. He is admitted to practice in Illinois, New York and before the United States Patent and Trademark Office.
Morris earned a J.D. from Fordham University School of Law and a Ph.D. in organic chemistry from Northwestern University. He received a B.A. in English literature from the University of Michigan.
Honigman’s IP Department consists of more than 80 legal professionals with experience in patent, trademark, copyright and trade secret services, including search, procurement, enforcement and anti-counterfeiting. The professionals in the IP Department serve clients from large corporations to start-up companies and have experience in numerous industries, including automotive (OEM and suppliers), advertising, banking, biotechnology, consumer products, e-commerce, electronics, fashion, food and beverage, gaming and hospitality, insurance, medical services and devices, pharmaceuticals, publishing (newspapers, books, magazines, multi-media), real estate, restaurant, retailing, software, telecommunications and transportation.